Second-generation antipsychotics during the lactation period a comparative systematic review on infant safety

Journal of Clinical Psychopharmacology

Volumn 36, Issue 3, 2016, Pages 244-252

  Uguz, Faruk ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

Author keywords

Antipsychotics; Breastfeeding; Postpartum period

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; BENZODIAZEPINE DERIVATIVE; ASENAPINE; ILOPERIDONE; LURASIDONE;

BREAST FEEDING; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG SAFETY; HUMAN; LACTATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; ADVERSE EFFECTS; BLOOD; CHILD HEALTH; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; NEWBORN; PROSPECTIVE STUDY; DOSE RESPONSE; DRUG SURVEILLANCE PROGRAM; MEDLINE;

ANTIPSYCHOTIC AGENTS; ARIPIPRAZOLE; BENZODIAZEPINES; BREAST FEEDING; FEMALE; HUMANS; INFANT HEALTH; INFANT, NEWBORN; LACTATION; PROSPECTIVE STUDIES; RISPERIDONE;

EID: 84961960553     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000491     Document Type: Review

References (63)

1. Freeman MP, Smith KW, Freeman SA, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63:284-287.
2. Russell EJ, Fawcett JM, Mazmanian D. Risk of obsessive-compulsive disorder in pregnant and postpartum women: A meta-analysis. J Clin Psychiatry. 2013;74:377-385.
3. Munk-Olsen T, Laursen TM, Mendelson T, et al. Risks and predictors of readmission for a mental disorder during the postpartum period. Arch Gen Psychiatry. 2009;66:189-195.
4. Sharma V. Treatment of postpartum psychosis: challenges and opportunities. Curr Drug Saf. 2008;3:76-81.
5. Klinger G, Stahl B, Fusar-Poli P, et al. Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev. 2013;10:308-317.
6. Robertson E, Jones I, Haque S, et al. Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis. Br J Psychiatry. 2005;186:258-259.
7. Doucet S, Jones I, Letourneau N, et al. Interventions for the prevention and treatment of postpartum psychosis: A systematic review. Arch Womens Ment Health. 2011;14:89-98.
8. Spinelli MG. Postpartum psychosis: detection of risk and management. Am J Psychiatry. 2009;166:405-408.
9. Pope CJ, Sharma V, Mazmanian D. Bipolar disorder in the postpartum period: management strategies and future directions. Womens Health (Lond Engl). 2014;10:359-371.
10. Sharma V, Burt VK, Ritchie HL. Bipolar II postpartum depression: detection, diagnosis, and treatment. Am J Psychiatry. 2009;166: 1217-1221.
11. Chaudron LH, Pies RW. The relationship between postpartum psychosis and bipolar disorder: A review. J Clin Psychiatry. 2003;64:1284-1292.
12. Gentile S. Infant safety with antipsychotic therapy in breast-feeding: A systematic review. J Clin Psychiatry. 2008;69:666-673.
13. Verdoux H, Tournier M, Bégaud B. Antipsychotic prescribing trends: A review of pharmaco-epidemiological studies. Acta Psychiatr Scand. 2010;121:4-10.
14. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700.
15. Brunner E, Falk DM, Jones DK, et al. Olanzapine in pregnancy and breastfeeding: A review of data from global safety surveillance. BMC Pharmacol Toxicol. 2013;14:38.
16. Goldstein DJ, Corbin LA, Wohlreich MM, et al. Olanzapine use during breast-feeding. Schizophr Res. 2002;53(suppl 1):S185.
17. Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol. 2000;20:399-403.
18. Gardiner SJ, Kristensen JH, Begg EJ, et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry. 2003;160:1428-1431.
19. Gilad O, Merlob P, Stahl B, et al. Outcome of infants exposed to olanzapine during breastfeeding. Breastfeed Med. 2011;6:55-58.
20. Croke S, Buist A, Hackett LP, et al. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol. 2002;5:243-247.
21. Whitworth A, Stuppaeck C, Yazdi K, et al. Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months. J Psychopharmacol. 2010;24:121-123.
22. Ambresin G, Berney P, Schulz P, et al. Olanzapine excretion into breast milk: A case report. J Clin Psychopharmacol. 2004;24:93-95.
23. Stiegler A, Schaletzky R, Walter G, et al. Olanzapine treatment during pregnancy and breastfeeding: A chance for women with psychotic illness? Psychopharmacology (Berl). 2014;231:3067-3069.
24. Lutz UC, Wiatr G, Orlikowsky T, et al. Olanzapine treatment during breast feeding: A case report. Ther Drug Monit. 2008;30:399-401.
25. Aydin B, Nayir T, Sahin S, et al. Olanzapine and quetiapine use during breastfeeding: excretion into breast milk and safe breastfeeding strategy. J Clin Psychopharmacol. 2015;35:206-208.
26. Kirchheiner J, Berghöfer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry. 2000;33: 78-80.
27. Friedman SH, Rosenthal MB. Treatment of perinatal delusional disorder: A case report. Int J Psychiatry Med. 2003;33:391-394.
28. Misri S, Corral M, Wardrop AA, et al. Quetiapine augmentation in lactation. A series of case reports. J Clin Psychopharmacol. 2006;26: 508-511.
29. Gentile S. Quetiapine-fluvoxamine combination during pregnancy and while breastfeeding. Arch Womens Ment Health. 2006;9:158-159.
30. Rampono J, Kristensen JH, Ilett KF, et al. Quetiapine and breast feeding. Ann Pharmacother. 2007;41:711-714.
31. Lee A, Giesbrecht E, Dunn E, et al. Excretion of quetiapine in breast milk. Am J Psychiatry. 2004;161:1715-1716.
32. Van Boekholt AA, Hartong EG, Huntjens-Fleuren H, et al. Quetiapine concentrations during exclusive breastfeeding and maternal quetiapine use. Ann Pharmacother. 2015;49:743-744.
33. Ritz S. Quetiapine monotherapy in postpartum onset bipolar disorder with a mixed affective state. Eur Neuropsychopharmacol. 2005; 15(suppl 3):S407.
34. Seppälä J. Quetiapine ('Seroquel') is effective and well tolerated in the treatment of psychotic depression during breast-feeding. Int J Neuropsychopharmacol. 2004;7(suppl 1):S245.
35. Ratnayake T, Libretto SE. No complications with risperidone treatment before and throughout pregnancy and during the nursing period. J Clin Psychiatry. 2002;63:76-77.
36. Weggelaar NM, Keijer WJ, Janssen PK. A case report of risperidone distribution and excretion into human milk: how to give good advice if you have not enough data available. J Clin Psychopharmacol. 2011;31: 129-131.
37. Ilett KF, Hackett LP, Kristensen JH, et al. Transfer of risperidone and 9-Hydroxyrisperidone into human milk. Ann Pharmacother. 2004;38: 273-276.
38. Hill RC, McIvor RJ, Wojnar-Horton RE. Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J Clin Psychopharmacol. 2000;20:285-86.
39. Aichhorn W, Stuppaeck C, Whitworth AB. Risperidone and breast-feeding. J Psychopharmacol. 2005;19:211-213.
40. Schlotterbeck P, Leube D, Kircher T, et al. Aripiprazole in human milk. Int J Neuropsychopharmacol. 2007;10:433.
41. Watanabe N, Kasahara M, Sugibayashi R, et al. Perinatal use of aripiprazole: A case report. J Clin Psychopharmacol. 2011;31:377-379.
42. Nordeng H, Gjerdalen G, BredeWR, et al. Transfer of aripiprazole to breast milk: A case report. J Clin Psychopharmacol. 2014;34:272-275.
43. Lutz UC, Hiemke C, Wiatr G, et al. Aripiprazole in pregnancy and lactation: A case report. J Clin Psychopharmacol. 2010;30:204-205.
44. Ilett KF, Watt F, Hackett LP, et al. Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression. Ther Drug Monit. 2010;32:704-707.
45. Teoh S, Ilett KF, Kohan R. Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia. Breastfeed Med. 2011;6:85-88.
46. Werremeyer A. Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. Am J Psychiatry. 2009; 166:1298.
47. Schlotterbeck P, Saur R, Hiemke C, et al. Low concentration of ziprasidone in human milk: A case report. Int J Neuropsychopharmacol. 2009;12: 437-438.
48. Mendhekar DN. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. J Neuropsychiatry Clin Neurosci. 2007;19:196-197.
49. Barnas C, Bergant A, Hummer M, et al. Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breastmilk. Am J Psychiatry. 1994;151:945.
50. Dev VJ, Krupp P. Adverse event profile and safety of clozapine. Rev Cont Pharmacother. 1995;6:197-208.
51. Sie SD, Wennink JM, van Driel JJ, et al. Maternal use of SSRIs, SNRIs and NASSAs: practical recommendations during pregnancy and lactation. Arch Dis Child Fetal Neonatal Ed. 2012;97:472-476.
52. Sachs HC; Committee On Drugs. The transfer of drugs and therapeutics into human breastmilk: An update on selected topics. Pediatrics. 2013;132: e796-e809.
53. Berle JO, Spigset O. Antidepressant use during breastfeeding. Curr Womens Health Rev. 2011;7:28-34.
54. Gentile S. Use of contemporary antidepressants during breastfeeding: A proposal for a specific safety index. Drug Saf. 2007;30: 107-121.
55. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother. 2004;38:1265-1271.
56. Van der Meer DH, Wieringa A, Wegner I, et al. Lactation studies of anticonvulsants: A quality review. Br J Clin Pharmacol. 2015;79: 558-565.
57. Chad L, Pupco A, Bozzo P, et al. Update on antidepressant use during breastfeeding. Can Fam Physician. 2013;59:633-634.
58. Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004;161:1066-1078.
59. Orsolini L, Bellantuono C. Serotonin reuptake inhibitors and breastfeeding: A systematic review. Hum Psychopharmacol. 2015;30:4-20.
60. Gentile S. A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium. Expert Opin Drug Saf. 2014;13: 1733-1742.
61. Mahmood I. Dosing in children: A critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings. Clin Pharmacokinet. 2014;53:327-346.
62. Loebstein R, Koren G. Clinical pharmacology and therapeutic drug monitoring in neonates and children. Pediatr Rev. 1998;19:423-428.
63. Faa G, Ekstrom J, Castagnola M, et al. A developmental approach to drug-induced liver injury in newborns and children. Curr Med Chem. 2012;19:4581-4594.